Home › NDC Lookup › Ingredients › Silver Nitrate Applicators › 12870-0001-01
Silver Nitrate Applicators 25 mg/100mg; 75 mg/100mg Stick — NDC 12870-0001-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Silver Nitrate Applicators 25 mg/100mg; 75 mg/100mg Stick — NDC 12870-0001-1 (Billing 12870-0001-01)

by Arzol Chemical Company · 10 PACKET in 1 BOX / 10 APPLICATOR in 1 PACKET / 100 mg in 1 APPLICATOR

This is a package of Silver Nitrate Applicators 25 mg/100mg; 75 mg/100mg Stick from Arzol Chemical Company, marketed since Jan 1937 and currently FDA-listed. It is the main listing for this product, which comes in 2 package sizes.

NDC 12870-0001-01
🏷️ FDA NDC (as labeled) 12870-0001-1 billing pads the package segment with a zero
This package
Contains100 mg in 1 applicator Pack sizes2 compare ↓
Main listing for product 12870-0001 · Also comes in: 100 applicators 12870-0001-2
Rx only On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 12870-0001-1 alone.

Record
FDA NDC Directory package listing · Human prescription drug
Code segments
12870 labeler · 0001 product · 1 package
Package marketed since
Jan 1, 1937
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Barcode (UPC-A, from the NDC)
3 1287000011 1
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 12870-0001-1
Product NDC 12870-0001
11-digit billing NDC 12870000101
NCPDP billing unit EA — each (per item)
RxCUI 1117536
UNII RU45X2JN0Z, 95IT3W8JZE
SPL Set ID 23b83457-8cbc-26f1-e054-00144ff8d46c
DEA schedule Non-controlled
Marketing category UNAPPROVED DRUG OTHER
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 1937-01-01
Route TOPICAL
Dosage form STICK
Substance POTASSIUM NITRATE; SILVER NITRATE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 90509902406340
GPI class Arzol Silver Nit Applicators
GCN Seq No 062055
GCN 97839
HICL code 017855
Ingredient (HICL) Silver Nitrate Applicator
HIC1 code L
Therapeutic class — broad (HIC1) Skin/Subcutaneous Tissue
HIC2 code L5
Therapeutic class — intermediate (HIC2) Keratolytics/Keratoplastics
HIC3 code L5A
Therapeutic class — specific (HIC3) Keratolytics
AHFS code 84:28.00.00
AHFS class Keratolytic Agents
FDB label name SILVER NITRATE APPLICATOR
FDB brand name Silver Nitrate Applicator
Legend status F — Federal legend — prescription drug or device
Quick answers
  • GSN (GCN sequence number): 062055
  • GCN: 97839
  • GPI-14 (Medi-Span): 90509902406340
  • HICL (First Databank): 017855
  • AHFS class code: 84:28.00.00
  • RxCUI (RxNorm): 1117536
Why two NDCs? The FDA registers this code as 12870-0001-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 12870-0001-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

Label name SILVER NITRATE APPLICATOR Ingredient Silver Nitrate Applicator
🧪 What is this product?

Silver nitrate applicators are stick-form topical products containing silver nitrate and potassium nitrate. Silver nitrate is typically used as a caustic agent to remove or destroy unwanted tissue growths, such as warts or granulation tissue, and has been used historically in wound care. Potassium nitrate functions as an oxidizing agent and is commonly included in such products to support the chemical action. This product is marketed without an approved FDA application.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 100 applicators
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
12870-0001-01 You're viewing this Main listing 10 PACKET in 1 BOX / 10 APPLICATOR in 1 PACKET / 100 mg in 1 APPLICATOR 1937-01-01 — Active
12870-0001-02 12870-0001-2 100 APPLICATOR in 1 VIAL / 100 mg in 1 APPLICATOR 1937-01-01 — Active

Pack size FAQ

What quantity is in this package?
This package is listed by the FDA — 10 packet in 1 box / 10 applicator in 1 packet / 100 mg in 1 applicator.
What NDC number is used to bill for this package of Silver Nitrate Applicators 25 mg/100mg; 75 mg/100mg Stick?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Styptstix 38.21 mg/1; 12.74 mg 00404-1000-01 Henry 12 tubes — — FDA listed —
Grafco Applicator 15 Cm 38.21 mg/1; 12.74 mg 12165-0100-01 GF 100 sticks — — FDA listed —
Grafco Applicator 30 Cm 52.451 mg/1; 17.486 mg 12165-0200-03 GF 100 sticks — — FDA listed —
Grafco Applicator 45 Cm 73.4314 mg/1; 24.4804 mg 12165-0300-01 GF 1 stick — — FDA listed —
Silver Nitrate Applicators 25 mg/100mg; 75 mg/100mgthis 12870-0001-01 Arzol 10 packets — — FDA listed —
Grafco Silver Nitrate (75% Silver Nitrate, 25% Potassium Nitrate) 12.74 mg/1; 38.21 mg 51662-1611-01 HF 100 sticks — — FDA listed —
Avoca Flexible Caustic Applicator 30 mg/40mg 65875-0101-09 Bray 10 vials — — FDA listed —
Swabs 25 g/100mL; 75 g/100mL 68599-6303-08 McKesson 10 swabs — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
1937
On the market since
Jan 1937
📍
2026
Currently FDA-listed
89 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

A current SPL was checked, but it does not contain a structured or narrative inactive-ingredient list for this product. This does not mean the product has no inactive ingredients.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerArzol Chemical Company
Labeler code12870
First marketedJan 1937
Product typeHuman Prescription Drug
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full prescribing information FDA SPL

The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration 💊 Dosage Forms and Strengths ⚠️ Warnings and Cautions ⚠️ Warnings 🤒 Adverse Reactions 📦 How Supplied / Storage and Handling 📦 Storage and Handling 📋 Description 📄 Other Information 📖 Instructions for Use 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 77 words ▾

INDICATIONS On the skin, applications of silver nitrate are recommended for cauterization of wounds and sluggish ulcers, also for removal of granulation tissue and warts. On mucous membranes, silver nitrate may be applied to small ulcers and aphthae in the mouth resulting from injury or stomatitis, to infected tonsils, to rectal fissures and fistulae, and to vaginal or cervical ulcerations or erosions. Epistaxis may be controlled by direct application to the site of hemorrhage within the nostrils.

⏱️ Dosage and Administration 44 words ▾

APPLICATION ARZOL may be applied direct to mucous membranes and other moist surfaces. In the case of dry skin, the applicator tip should be dipped in water immediately before use. Apply carefully to the area to be treated. DO NOT USE ON THE EYES.

💊 Dosage Forms and Strengths 24 words ▾

Silver Nitrate 75% Potassium Nitrate 25%

Silver Nitrate 75% Potassium Nitrate 25%

(Silver Nitrate 75%) (Potassium Nitrate 25%)

Silver Nitrate 75% Potassium Nitrate 25%

⚠️ Warnings and Cautions 59 words ▾

WARNING: Keep out of reach of children. Keep in dry and dark place. Do not use on the eyes.

Warning: Do not use on the eyes. Keep out of reach of children. Keep in a dry and dark place.

Warning: Do not use on the eyes. Keep out of reach of children. Keep in a dry and dark place.

⚠️ Warnings 81 words ▾

SIDE EFFECTS Silver nitrate blackens the tissues to which it is applied but this discoloration gradually disappears. In the case of applicators, poisoning from ingestion is rare.

POISON

CAUTION: Federal law prohibits dispensing without prescription. Do not open this box or dispense packets or applicators separately.

POISON

Caution: Federal law prohibits dispensing without prescription. Do not dispense packets or applicators separately.

NOT FOR RESALE

Caution: Federal law prohibits dispensing without prescription. Do not open this tube or dispense applicators separately.

POISON

🤒 Adverse Reactions 19 words ▾

HAZARDS Long continued applications to large areas may produce argyria, a slate-blue discoloration of the skin and mucous membranes.

📦 How Supplied / Storage and Handling 30 words ▾

AVAILABILITY ARZOL Silver Nitrate Applicators are supplied in boxes of 100 containing 10 packets each with 10 applicators; also, in plastic tubes containing 100 applicators.

100 APPLICATORS

TEN (10) applicators

📦 Storage and Handling 136 words ▾

STABILITY PRECAUTIONS Light causes the silver in the tip to oxidize and turn brown in color. This does not affect the therapeutic action of the tip and the oxidized film readily dissolves when dipped in water. Moisture has a deteriorating effect on the tip. It will cause the tip to break or loosen from the applicator; therefore the applicators should be kept in a dry and dark place.

Stability Precautions Light causes the silver in the tip to oxidize and turn brown in color. This does not affect the therapeutic action of the tip and the oxidized film readily dissolves when dipped in water. Moisture has a deteriorating effect on the tip. It will cause the tip to break or loosen from the applicator; therefore the applicators should be kept in a dry and dark place.

📋 Description 96 words ▾

for Simplified Silver Nitrate Therapy ARZOL Silver Nitrate Applicators provide a simple and convenient means of treating small lesions of the skin and mucous membranes. On contact with living tissue, silver nitrate acts as an escharotic. Deep action is avoided by the formation of a dense surface film of coagulated albumin.

Silver nitrate is a powerful chemical germicide. Despite precipitation, it retains substantial germicidal potency even in the presence of large quantities of albuminous material, possibly by gradually redissolving the silver.

FOR SIMPLIFIED SILVER NITRATE THERAPY

for Simplified Silver Nitrate Therapy

For Simplified Silver Nitrate Therapy

📄 Other Information ~1 min read ▾

ANTIDOTE In case of accidental poisoning, follow these directions: External: Eye Exposure -- First: Wash out the eye with lukewarm water for at least fifteen (15) minutes then call your physician or go to your nearest Emergency Room. Skin Exposure -- First: Wash the area very thoroughly with soap and water then call your physician. Internal: First: Give one (1) glass of milk or water then call your physician or go to your nearest Emergency Room.

ANTIDOTE In case of accidental poisoning, follow these directions. EXTERNAL - EYE EXPOSURE: FIRST: Wash out the eye with lukewarm water for at least fifteen (15) minutes THEN: call your physician or go to your nearest Emergency Room. SKIN EXPOSURE: FIRST: Wash the areas very thoroughly with soap and water THEN: call your physician. INTERNAL: FIRST: Give one (1) glass of milk or water THEN: call your physician or go to your nearest Emergency Room.

ANTIDOTE In case of accidental poisoning, follow these directions: External: Eye Exposure: First: Wash out the eye with lukewarm water for at least fifteen (15) minutes then call your physician or go to your nearest Emergency Room. Skin Exposure: First: Wash the area very thoroughly with soap and water then call your physician. Internal: First: Give one (1) glass of milk or water then call your physician or go to your nearest Emergency Room.

In case of accidental poisoning, follow these directions: ANTIDOTE External: Eye Exposure: First: Wash out the eye with lukewarm water for at least fifteen (15) minutes then call your physician or go to your nearest Emergency Room. Skin Exposure: First: Wash the area very thoroughly with soap and water then call your physician. Internal: First: Give one (1) glass of milk or water then call your physician or go to your nearest Emergency Room.

📖 Instructions for Use ~3 min read ▾

Arzol Insert Front Arzol Insert Back ARZOL® Silver Nitrate Applicators Silver Nitrate 75% Potassium Nitrate 25% for Simplified Silver Nitrate Therapy ARZOL Silver Nitrate Applicators provide a simple and convenient means of treating small lesions of the skin and mucous membranes. On contact with living tissue, silver nitrate acts as an escharotic. Deep action is avoided by the formation of a dense surface film of coagulated albumin.

Silver nitrate is a powerful chemical germicide. Despite precipitation, it retains substantial germicidal potency even in the presence of large quantities of albuminous material, possibly by gradually redissolving the silver. SPECIAL PROPERTIES The combination of silver nitrate with potassium nitrate has been called toughened silver nitrate , also lunar caustic .

When the tip of the applicator is impregnated with this compound, as in ARZOL , the silver nitrate can be applied quickly and conveniently to the precise area to be treated without spread of the escharotic to adjacent healthy tissues. Exposure to light causes the silver in the tip to oxidize and turn brown in color. This discoloration does not affect the therapeutic action of the tip and the oxidized film readily dissolves when dipped in water.

Moisture has a deteriorating effect on the tip. It may cause it to break or loosen from the applicator; therefore the applicators should be kept in a dry place. CAUTION: Silver Nitrate is a caustic compound, the improper use of which may cause chemical burns.

Silver Nitrate mixes with body fluids; this mixture is caustic and tissue damage may result if not removed quickly. Contact of Silver Nitrate applicators on neonates (as in use on the umbilicus) and on thin delicate skin should be extremely short in duration. INDICATIONS On the skin, applications of silver nitrate are recommended for cauterization of wounds and sluggish ulcers, also for removal of granulation tissue and warts.

On mucous membranes, silver nitrate may be applied to small ulcers and aphthae in the mouth resulting from injury or stomatitis, to infected tonsils, to rectal fissures and fistulae, and to vaginal or cervical ulcerations or erosions. Epistaxis may be controlled by direct application to the site of hemorrhage within the nostrils. APPLICATION ARZOL may be applied direct to mucous membranes and other moist surfaces.

In the case of dry skin, the applicator tip should be dipped in water immediately before use. Apply carefully to the area to be treated. DO NOT USE ON THE EYES.

SIDE EFFECTS Silver nitrate blackens the tissues to which it is applied but this discoloration gradually disappears. In the case of applicators, poisoning from ingestion is rare. ANTIDOTE In case of accidental poisoning, follow these directions: External: Eye Exposure -- First: Wash out the eye with lukewarm water for at least fifteen (15) minutes then call your physician or go to your nearest Emergency Room.

Skin Exposure -- First: Wash the area very thoroughly with soap and water then call your physician. Internal: First: Give one (1) glass of milk or water then call your physician or go to your nearest Emergency Room. HAZARDS Long continued applications to large areas may produce argyria, a slate-blue discoloration of the skin and mucous membranes.

AVAILABILITY ARZOL Silver Nitrate Applicators are supplied in boxes of 100 containing 10 packets each with 10 applicators; also, in plastic tubes containing 100 applicators.

📄 Package Label / Principal Display Panel ~2 min read ▾

Arzol Box Packaging Arzol® Silver Nitrate Applicators Silver Nitrate 75% Potassium Nitrate 25% FOR SIMPLIFIED SILVER NITRATE THERAPY POISON CAUTION: Federal law prohibits dispensing without prescription. Do not open this box or dispense packets or applicators separately. WARNING: Keep out of reach of children.

Keep in dry and dark place. Do not use on the eyes. 100 APPLICATORS ANTIDOTE In case of accidental poisoning, follow these directions.

EXTERNAL - EYE EXPOSURE: FIRST: Wash out the eye with lukewarm water for at least fifteen (15) minutes THEN: call your physician or go to your nearest Emergency Room. SKIN EXPOSURE: FIRST: Wash the areas very thoroughly with soap and water THEN: call your physician. INTERNAL: FIRST: Give one (1) glass of milk or water THEN: call your physician or go to your nearest Emergency Room.

STABILITY PRECAUTIONS Light causes the silver in the tip to oxidize and turn brown in color. This does not affect the therapeutic action of the tip and the oxidized film readily dissolves when dipped in water. Moisture has a deteriorating effect on the tip.

It will cause the tip to break or loosen from the applicator; therefore the applicators should be kept in a dry and dark place.

Arzol Inner Envelope Packaging ARZOL® Silver Nitrate Applicators (Silver Nitrate 75%) (Potassium Nitrate 25%) for Simplified Silver Nitrate Therapy POISON TEN (10) applicators Caution: Federal law prohibits dispensing without prescription. Do not dispense packets or applicators separately. Warning: Do not use on the eyes.

Keep out of reach of children. Keep in a dry and dark place. NOT FOR RESALE ANTIDOTE In case of accidental poisoning, follow these directions: External: Eye Exposure: First: Wash out the eye with lukewarm water for at least fifteen (15) minutes then call your physician or go to your nearest Emergency Room.

Skin Exposure: First: Wash the area very thoroughly with soap and water then call your physician. Internal: First: Give one (1) glass of milk or water then call your physician or go to your nearest Emergency Room. Stability Precautions Light causes the silver in the tip to oxidize and turn brown in color.

This does not affect the therapeutic action of the tip and the oxidized film readily dissolves when dipped in water. Moisture has a deteriorating effect on the tip. It will cause the tip to break or loosen from the applicator; therefore the applicators should be kept in a dry and dark place.

Arzol Vial Packaging ARZOL Silver Nitrate Applicators Silver Nitrate 75% Potassium Nitrate 25% For Simplified Silver Nitrate Therapy Caution: Federal law prohibits dispensing without prescription. Do not open this tube or dispense applicators separately. Warning: Do not use on the eyes.

Keep out of reach of children. Keep in a dry and dark place. POISON In case of accidental poisoning, follow these directions: ANTIDOTE External: Eye Exposure: First: Wash out the eye with lukewarm water for at least fifteen (15) minutes then call your physician or go to your nearest Emergency Room.

Skin Exposure: First: Wash the area very thoroughly with soap and water then call your physician. Internal: First: Give one (1) glass of milk or water then call your physician or go to your nearest Emergency Room.

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Silver Nitrate Applicators — the ingredient across all brands.

Top reported reactions

Burkholderia Test Positive2
Covid-192
Endotracheal Intubation2
Dyspnoea1
Lung Assist Device Therapy1
Pain1
Respiratory Failure1

Reporter sex

0 reports
Male · 100%
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Finished prescription product Marketed without an FDA application

Listed without an FDA application

This product's marketing category indicates it is marketed without an approved FDA application (no NDA, ANDA, or BLA on file). Having an NDC does not by itself establish FDA approval — the NDC Directory is a listing system, not an approval decision. Approval-linked data such as Orange Book therapeutic-equivalence ratings therefore does not apply.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Unapproved Drug Other". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Arzol Chemical Company. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 100 applicators (12870-0001-02). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Arzol Chemical Company is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as a prescription product, so it is dispensed under a prescriber's order. Your pharmacist can tell you whether any over-the-counter forms of the same medication exist.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 12869-0803-01 · Corden 12875-1080-00 · Bayer →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.